Company Overview of ISA Pharmaceuticals B.V.
ISA Pharmaceuticals B.V., a biopharmaceutical company, develops therapeutic vaccines for cancer and infectious diseases. It offers HPV-SLP vaccine for the treatment of patients suffering from human Papilloma virus, as well as vaccines against ovarian and colorectal cancer, melanoma, and tuberculosis. The company was founded in 2004 and is based in Leiden, the Netherlands.
Niels Bohrweg 11-13
Leiden, 2333 CA
Founded in 2004
31 71 332 2310
31 71 332 2311
Key Executives for ISA Pharmaceuticals B.V.
ISA Pharmaceuticals B.V. Key Developments
Similar Private Companies By Industry
|ACS Biomarker B.V.||Europe|
|Aduro Biotech Europe||Europe|
|Agventure Exploitatie BV||Europe|
|Amarna Therapeutics B.V.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact ISA Pharmaceuticals B.V., please visit www.isa-pharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.